Metabolomics in Detection of Chemotoxicity

Chemotherapy drugs capable to cause significant, irreversible, life threatening organ damage which is distressing for patients and might affect the optimal delivery of treatment. Various studies have predicted the risk factors for drug induced organ damage because of lack of biomarker to pick-up these changes in early phase causes potential morbidity and mortality. Metabolomics can address relation between gene, drugs environment and thus increase our ability to predict individual variation in drug response phenotypes.

    Related Conference of Metabolomics in Detection of Chemotoxicity

    May 10-11, 2019

    8th Asia Pacific Glycobiology Congress

    Tokyo, Japan
    July 11-12, 2019

    8th Glycobiology World Congress

    Zurich, Switzerland
    May 10-11, 2019

    4th International Conference on Enzymology & Molecular Biology

    | Radisson Hotel Narita | Tokyo, Japan
    October 07-08, 2019

    4th International Conference on Molecular Biology & Nucleic Acids

    Chicago, Illinois, USA

    Metabolomics in Detection of Chemotoxicity Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in